Recent Progress for the Synthesis of Selected Carbocyclic Nucleosides
- 29 September 2015
- journal article
- review article
- Published by Taylor & Francis in Future Medicinal Chemistry
- Vol. 7 (13) , 1809-1828
Abstract
Nucleoside analogs are extremely useful for the development of therapeutic agents to control viral diseases and cancer. Among the numerous modifications on the nucleoside skeleton, replacement of the oxygen of the furanose ring by a CH2 group resulted in increased flexibility and higher resistance to phosphorylases and led to carbocyclic nucleoside analogs (or carbanucleosides). The broad spectrum of biological activities of carbocyclic nucleosides led to tremendous research interest in their syntheses. The article documents recent strategies for the synthesis of active carbocyclic nucleosides by presenting individual case studies, such as the neplanocins, entecavir and selected fluorinated carbocyclic nucleosides. Furthermore, it provides new insights into new directions for more potent and active carbocyclic nucleoside analogs.Keywords
Funding Information
- French Ministère de l'Education Nationale, de l'Enseignement Supérieur et de la Recherche (ANR-11-LABX-0029)
This publication has 39 references indexed in Scilit:
- Total Synthesis of EntecavirThe Journal of Organic Chemistry, 2013
- Advances in the enantioselective synthesis of carbocyclic nucleosidesChemical Society Reviews, 2013
- Synthesis and Evaluation of Novel 6′,6′-Difluoro 5′-Deoxycarbocyclic Phosphonic Acid Nucleosides as Antiviral AgentsNucleosides, Nucleotides & Nucleic Acids, 2013
- (+)-Neplanocin F, 2′-fluoroneplanocin, and a 6′-isoneplanocin via a common versatile cyclopentenol precursorTetrahedron Letters, 2011
- Synthesis of the 5′‐Fluoro‐2′β‐methyl Analogues of NeplanocinEuropean Journal of Organic Chemistry, 2011
- X-ray Crystal Structure and Binding Mode Analysis of Human S-Adenosylhomocysteine Hydrolase Complexed with Novel Mechanism-Based Inhibitors, Haloneplanocin A AnaloguesJournal of Medicinal Chemistry, 2011
- Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy #Hepatology, 2009
- Synthesis of Nucleoside Di- and Triphosphates and Dinucleoside Polyphosphates with cycloSal-NucleotidesThe Journal of Organic Chemistry, 2009
- Hepatitis B virus mutations associated with antiviral therapyJournal of Medical Virology, 2006
- S-Adenosyl-L-homocysteine hydrolase as a target for antiviral chemotherapyJournal of Medicinal Chemistry, 1991